US-listed company Processa is evaluating corporate cryptocurrency financial strategies

Foresight News reports that U.S. pharmaceutical company Processa (NASDAQ: PCSA) has announced a strategic investment, though the specific amount was not disclosed, and is currently evaluating a corporate cryptocurrency financial strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing the related strategy. Processa stated that it will explore the use of blockchain assets to support its clinical development projects, strictly adhering to regulatory standards.